ArticleOncoimmunology

Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.